Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis-Reference-Cited by-同舟云学术

Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis

Published:2017-11 Issue: Volume:266 Page:226-237
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

El-Mezayen Nesrine S.,El-Hadidy Wessam F.,El-Refaie Wessam M.,Shalaby Th.I.,Khattab Mahmoud M.,El-Khatib Aiman S.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference95 articles.

1. The global burden of liver disease: the major impact of China;Wang;Hepatology,2014

2. Hepatic fibrosis: a global clinical problem;Pinzani;Stellate Cells Health Dis.,2015

3. Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis;Dobie;F1000Research,2016

4. Liver transplantation for viral hepatitis in 2015;Ferrarese;World J. Gastroenterol.,2016

5. Regression of liver fibrosis,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis;ACS Nano;2023-11-23

2. MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?;Cancers;2023-11-23

3. Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways;European Journal of Pharmacology;2023-11

4. Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling;Stem Cells and Development;2023-10-01

5. Prospective therapeutics for intestinal and hepatic fibrosis;Bioengineering & Translational Medicine;2023-08-02